These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 32783300
1. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme. Bennett KF, Waller J, McBride E, Forster AS, Di Gessa G, Kitchener H, Marlow L. BJOG; 2021 Mar; 128(4):745-754. PubMed ID: 32783300 [Abstract] [Full Text] [Related]
4. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Gilham C, Sargent A, Kitchener HC, Peto J. Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027 [Abstract] [Full Text] [Related]
5. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J, ARTISTIC Trial Study Group. Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902 [Abstract] [Full Text] [Related]
7. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. McCaffery KJ, Irwig L, Turner R, Chan SF, Macaskill P, Lewicka M, Clarke J, Weisberg E, Barratt A. BMJ; 2010 Feb 23; 340():b4491. PubMed ID: 20179125 [Abstract] [Full Text] [Related]
9. The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial. Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P. Int J Gynecol Cancer; 2008 Feb 23; 18(4):743-8. PubMed ID: 17944916 [Abstract] [Full Text] [Related]
10. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study. Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, Chan KK, Ngan HY. Acta Obstet Gynecol Scand; 2011 May 23; 90(5):445-51. PubMed ID: 21306349 [Abstract] [Full Text] [Related]
16. Human papillomavirus test with cytology triage in organized screening for cervical cancer. Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J. Acta Obstet Gynecol Scand; 2016 Nov 23; 95(11):1220-1227. PubMed ID: 27591407 [Abstract] [Full Text] [Related]
17. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A. BJOG; 2013 Sep 23; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222 [Abstract] [Full Text] [Related]
18. Exploring reasons for variations in anxiety after testing positive for human papillomavirus with normal cytology: a comparative qualitative study. McBride E, Marlow LAV, Bennett KF, Stearns S, Waller J. Psychooncology; 2021 Jan 23; 30(1):84-92. PubMed ID: 32909308 [Abstract] [Full Text] [Related]
19. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia. Canfell K, Saville M, Caruana M, Gebski V, Darlington-Brown J, Brotherton J, Heley S, Castle PE. BMJ Open; 2018 Jan 26; 8(1):e016700. PubMed ID: 29374658 [Abstract] [Full Text] [Related]
20. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting. Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E. J Clin Virol; 2016 Mar 26; 76 Suppl 1():S29-S39. PubMed ID: 26643051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]